ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3053 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3053; 2) Community: the network communities that were significantly associated with the response to NSC 3053; 3) Molecule: the relationships between components within communities and NSC 3053; 4) MDR: the compounds that were significantly associated with the NSC 3053.

NSC Compound Enrichment Correlation
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0376362543535812 0.64855401
NSC 135371 Null 0.0376362543535812 0.31914485
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0376362543535812 0.054752068
NSC 255105 GELDANAMYCIN ANALOG 0.0376362543535812 0.22390825
NSC 354671 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2- thiazolyl)ethylidene]hydrazide 0.0376362543535815 0.17906503
NSC 363812 Tetraplatin 0.0376362543535815 0.56499888
NSC 38643 Lenamycin 0.0376362543535815 0.25659385
NSC 603553 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(4-methoxy phenyl)-, hydrochloride 0.0376362543535815 0.25382998
NSC 618757 (E,E)-Piperidinium, 3,5-bis{[4-(dimethylamino)phenyl]methylene}-1,1-dimethyl-4-oxo, iodide 0.0376362543535815 0.55776179
NSC 621335 Null 0.0376362543535815 0.41515661
Total:171  Current:135    [First] [Prev] [Next] [Last]